134 related articles for article (PubMed ID: 26832356)
1. Traceability, reproducibility and clinical evaluation of Sansure Realtime HCV RNA assay.
Huang X; Deng Z; Long L; Chen J; Tan D; Zhu L; Fan X; Shen T; Lu F
BMC Infect Dis; 2016 Feb; 16():47. PubMed ID: 26832356
[TBL] [Abstract][Full Text] [Related]
2. Performance of two Real-Time RT-PCR assays for quantitation of hepatitis C virus RNA: evaluation on HCV genotypes 1-4.
Elkady A; Tanaka Y; Kurbanov F; Sugauchi F; Sugiyama M; Khan A; Ali EM; Mouhamed L; Abou el-fetouh S; AbdEl-Hameed AR; Mizokami M
J Med Virol; 2010 Nov; 82(11):1878-88. PubMed ID: 20872714
[TBL] [Abstract][Full Text] [Related]
3. Clinical evaluation of the COBAS Ampliprep/COBAS TaqMan for HCV RNA quantitation in comparison with the branched-DNA assay.
Pittaluga F; Allice T; Abate ML; Ciancio A; Cerutti F; Varetto S; Colucci G; Smedile A; Ghisetti V
J Med Virol; 2008 Feb; 80(2):254-60. PubMed ID: 18098148
[TBL] [Abstract][Full Text] [Related]
4. Analytical characteristics and comparative evaluation of Aptima HCV quant Dx assay with the Abbott RealTime HCV assay and Roche COBAS AmpliPrep/COBAS TaqMan HCV quantitative test v2.0.
Worlock A; Blair D; Hunsicker M; Le-Nguyen T; Motta C; Nguyen C; Papachristou E; Pham J; Williams A; Vi M; Vinluan B; Hatzakis A
Virol J; 2017 Apr; 14(1):66. PubMed ID: 28372576
[TBL] [Abstract][Full Text] [Related]
5. Diagnosis and monitoring of HCV infection using the cobas
Yao JD; Young S; Heilek GM; Marino E; Paxinos EE; Marins EG; Valsamakis A
J Clin Virol; 2018 May; 102():63-69. PubMed ID: 29518694
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the COBAS(®) AmpliPrep/COBAS(®) TaqMan(®) HCV Test, v2.0 and comparison to assays used in routine clinical practice in an international multicenter clinical trial: The ExPECT study.
Kessler HH; Cobb BR; Wedemeyer H; Maasoumy B; Michel-Treil V; Ceccherini-Nelli L; Bremer B; Hübner M; Helander A; Khiri H; Heilek G; Simon CO; Luk K; Aslam S; Halfon P
J Clin Virol; 2015 Jun; 67():67-72. PubMed ID: 25959162
[TBL] [Abstract][Full Text] [Related]
7. The New Aptima HCV Quant Dx Real-time TMA Assay Accurately Quantifies Hepatitis C Virus Genotype 1-6 RNA.
Chevaliez S; Dubernet F; Dauvillier C; Hézode C; Pawlotsky JM
J Clin Virol; 2017 Jun; 91():5-11. PubMed ID: 28380393
[TBL] [Abstract][Full Text] [Related]
8. Performance evaluation of the Aptima
Garbuglia AR; Bibbò A; Sciamanna R; Pisciotta M; Capobianchi MR
J Clin Virol; 2017 Jul; 92():1-6. PubMed ID: 28475925
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of an automated, highly sensitive, real-time PCR-based assay (COBAS Ampliprep/COBAS TaqMan) for quantification of HCV RNA.
Sarrazin C; Dragan A; Gärtner BC; Forman MS; Traver S; Zeuzem S; Valsamakis A
J Clin Virol; 2008 Oct; 43(2):162-8. PubMed ID: 18692434
[TBL] [Abstract][Full Text] [Related]
10. Multicentric performance analysis of HCV quantification assays and its potential relevance for HCV treatment.
Wiesmann F; Naeth G; Berger A; Hirsch HH; Regenass S; Ross RS; Sarrazin C; Wedemeyer H; Knechten H; Braun P
Med Microbiol Immunol; 2016 Jun; 205(3):263-8. PubMed ID: 26666643
[TBL] [Abstract][Full Text] [Related]
11. Analytical and clinical performance of the Hologic Aptima HCV Quant Dx Assay for the quantification of HCV RNA in plasma samples.
Schønning K; Pedersen MS; Johansen K; Landt B; Nielsen LG; Weis N; Westh H
J Virol Methods; 2017 Oct; 248():159-165. PubMed ID: 28732692
[TBL] [Abstract][Full Text] [Related]
12. Comparison of conventional PCR with real-time PCR and branched DNA-based assays for hepatitis C virus RNA quantification and clinical significance for genotypes 1 to 5.
Sarrazin C; Gärtner BC; Sizmann D; Babiel R; Mihm U; Hofmann WP; von Wagner M; Zeuzem S
J Clin Microbiol; 2006 Mar; 44(3):729-37. PubMed ID: 16517847
[TBL] [Abstract][Full Text] [Related]
13. Multilaboratory comparison of hepatitis C virus viral load assays.
Caliendo AM; Valsamakis A; Zhou Y; Yen-Lieberman B; Andersen J; Young S; Ferreira-Gonzalez A; Tsongalis GJ; Pyles R; Bremer JW; Lurain NS
J Clin Microbiol; 2006 May; 44(5):1726-32. PubMed ID: 16672399
[TBL] [Abstract][Full Text] [Related]
14. Genotype impact on HCV RNA levels determined with the VERSANT HCV RNA 1.0 assay (kPCR).
Kessler HH; Hübner M; Konrad PM; Stelzl E; Stübler MM; Baser MH; Santner BI
J Clin Virol; 2013 Nov; 58(3):522-7. PubMed ID: 24095028
[TBL] [Abstract][Full Text] [Related]
15. Clinical performance of the VERIS HCV assay for hepatitis C virus RNA quantification.
Izquierdo L; Prégermain C; Hottelet C; Decombe G; Roque-Afonso AM
J Clin Virol; 2017 Aug; 93():1-7. PubMed ID: 28550721
[TBL] [Abstract][Full Text] [Related]
16. Multicenter evaluation of the performance characteristics of the bayer VERSANT HCV RNA 3.0 assay (bDNA).
Elbeik T; Surtihadi J; Destree M; Gorlin J; Holodniy M; Jortani SA; Kuramoto K; Ng V; Valdes R; Valsamakis A; Terrault NA
J Clin Microbiol; 2004 Feb; 42(2):563-9. PubMed ID: 14766817
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the Abbott investigational use only RealTime hepatitis C virus (HCV) assay and comparison to the Roche TaqMan HCV analyte-specific reagent assay.
Pyne MT; Konnick EQ; Phansalkar A; Hillyard DR
J Clin Microbiol; 2009 Sep; 47(9):2872-8. PubMed ID: 19625475
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the Roche COBAS AmpliPrep/COBAS TaqMan HCV Test.
Pyne MT; Hillyard DR
Diagn Microbiol Infect Dis; 2013 Sep; 77(1):25-30. PubMed ID: 23806661
[TBL] [Abstract][Full Text] [Related]
19. Real-world performance of the NeuMoDx™ HCV Quant Test for quantification of hepatitis C virus (HCV)-RNA.
Lübke N; Walker A; Obermeier M; Camdereli J; Paluschinski M; Walotka L; Schupp AK; Tometten I; Hauka S; Heger E; Timm J
J Virol Methods; 2024 Jun; 327():114937. PubMed ID: 38614281
[TBL] [Abstract][Full Text] [Related]
20. Detection of HCV genotypes 1b and 2a by a reverse transcription loop-mediated isothermal amplification assay.
Zhao N; Liu J; Sun D
J Med Virol; 2017 Jun; 89(6):1048-1054. PubMed ID: 27935066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
